These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24607201

  • 1. A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.
    Evora AO, Castro RA, Maria TM, Silva MR, Ter Horst JH, Canotilho J, Eusébio ME.
    Int J Pharm; 2014 May 15; 466(1-2):68-75. PubMed ID: 24607201
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL, Carneiro RL.
    J Pharm Biomed Anal; 2014 Feb 15; 89():166-75. PubMed ID: 24291798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC, Martín C, Goñi MM, Rodríguez-Espinosa C, Tros de Ilarduya-Apaolaza MC, Sánchez M.
    J Pharm Sci; 1994 Feb 15; 83(2):174-7. PubMed ID: 8169784
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations.
    Pallipurath AR, Civati F, Sibik J, Crowley C, Zeitler JA, McArdle P, Erxleben A.
    Int J Pharm; 2017 Aug 07; 528(1-2):312-321. PubMed ID: 28603011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.
    Chow SF, Chen M, Shi L, Chow AH, Sun CC.
    Pharm Res; 2012 Jul 07; 29(7):1854-65. PubMed ID: 22359146
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid/saccharin for improvement of wettability and dissolution rate.
    Hyun SM, Lee BJ, Abuzar SM, Lee S, Joo Y, Hong SH, Kang H, Kwon KA, Velaga S, Hwang SJ.
    Int J Pharm; 2019 Jan 10; 554():61-71. PubMed ID: 30347274
    [Abstract] [Full Text] [Related]

  • 19. Solid phase drug-drug pharmaceutical co-crystal formed between pyrazinamide and diflunisal: Structural characterization based on terahertz/Raman spectroscopy combining with DFT calculation.
    Wu X, Wang Y, Xue J, Liu J, Qin J, Hong Z, Du Y.
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jun 15; 234():118265. PubMed ID: 32203686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.